Global Q-PCR and D-PCR Devices Market, By Technology (Quantitative PCR and Digital PCR), Products and Services (Reagents, Consumables, Instruments and Software), Application (Clinical Applications, Research, Forensic and Others), End User (Hospitals, Diagnostic Centres, Research Laboratories, Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations and Forensic Laboratories) – Industry Trends and Forecast to 2031.
Q-PCR and D-PCR Devices Market Analysis and Size
The Q-PCR and D-PCR devices market serves diverse sectors. In clinical applications, they aid in disease diagnosis, monitoring treatment response, and detecting genetic mutations. In research, they facilitate gene expression analysis, biomarker discovery, and drug development. Forensically, they contribute to DNA profiling and identification. Other applications include agriculture, environmental monitoring, and food safety, reflecting their versatility and importance across various fields.
Data Bridge Market Research analyses that the global Q-PCR and D-PCR devices market, which was USD 9.79 billion in 2023, is expected to reach USD 19.58 billion by 2031, at a CAGR of 9.05% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Quantitative PCR and Digital PCR), Products and Services (Reagents, Consumables, Instruments and Software), Application (Clinical Applications, Research, Forensic and Others), End User (Hospitals, Diagnostic Centres, Research Laboratories, Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations and Forensic Laboratories)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc.(U.S.), Bio-Rad Laboratories, Inc.(U.S.), QIAGEN (Germany), Takara Bio Inc. (Japan), Agilent Technologies, Inc.(U.S.), bioMérieux SA (France), Danaher(U.S.), Abbott(U.S.), Merck KGaA (Germany), BD (U.S.), Promega Corporation(U.S.), Eppendorf AG (Germany), Analytik Jena GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Enzo Life Sciences, Inc.(U.S.), Cole-Parmer Instrument Company, LLC.(U.S.), BIONEER CORPORATION (South Korea), ELITechGroup (France), Quantabio(U.S.)
|
|
Market Opportunities
|
|
Market Definition
Quantitative polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices are molecular biology instruments. Quantitative polymerase chain reaction measures DNA amplification in real-time, providing quantitative data on target DNA or RNA molecules. DIGITAL polymerase chain reaction partitions samples into many reactions, enabling absolute quantification of nucleic acids by counting positive reactions, offering high sensitivity and precision.
Global Q-PCR and D-PCR Devices Market Dynamics
Drivers
- Technological Advancements Enhancing Precision and Efficiency
The technological advancements have led to the development of more accurate and sensitive PCR devices, driving their adoption across various industries such as healthcare, pharmaceuticals, and research. The improved capabilities of these devices enable faster and more reliable detection of nucleic acids, aiding in disease diagnosis, drug development, and genetic research. Ultimately, technological innovation stands as a key driver propelling the expansion of the Q-PCR and D-PCR devices market.
- Increasing Prevalence of Infectious Diseases Globally
As infectious diseases pose significant health threats, there is a growing need for rapid and accurate diagnostic solutions provided by Q-PCR and D-PCR devices. These technologies enable early detection and monitoring of infections, facilitating timely treatment interventions and infection control measures. Consequently, the market for Q-PCR and D-PCR devices is driven by the imperative to combat infectious diseases effectively, making it a crucial driver in the market's expansion.
Opportunities
- Rising Demand for Personalized Medicine Fuels Growth
These for Q-PCR and D-PCR devices play a pivotal role in identifying genetic variations and biomarkers associated with diseases, guiding treatment decisions and optimizing patient outcomes. Through enabling precise molecular analysis at a rapid pace, Q-PCR and D-PCR devices empower healthcare providers to deliver targeted therapies and interventions. This trend presents a significant opportunity for market expansion, catering to the evolving needs of personalized healthcare.
- Collaborations Between Academia and Industry Drive Innovation
Academic institutions bring cutting-edge research and scientific expertise, while industry partners offer commercialization capabilities and market insights. Together, they drive advancements in device technology, experimental protocols, and application development. By leveraging each other's strengths, these collaborations accelerate the translation of research findings into practical solutions, meeting evolving market demands. This collaborative approach not only enhances product development but also opens doors for new partnerships and investment opportunities, driving further market growth.
Restraints/Challenges
- High Initial Investment Costs Deter Adoption Rates
The high initial investment costs limits market growth by impeding entry for smaller players and hindering expansion for existing ones. Companies may struggle to justify the upfront expenses, slowing down innovation and technological advancements. Additionally, higher costs may deter potential customers, particularly in resource-constrained settings or industries with tight budgets, thus constraining the overall market potential and adoption rates.
- Risk of Contamination Compromises Assay Accuracy
The risk of contamination undermines the reliability of results, leading to mistrust among users and potentially impacting decision-making processes in research, clinical, and industrial settings. Contamination-related inaccuracies may also result in wasted resources and time spent troubleshooting issues, reducing overall efficiency. Consequently, the market faces hurdles in gaining and retaining customer trust, inhibiting widespread adoption and potentially stalling market growth as users seek alternative solutions.
This global Q-PCR and D-PCR devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Q-PCR and D-PCR devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2023, Walgreens responds to the peak respiratory illness season in the U.S. by offering flu and COVID-19 testing services. This initiative highlights the growing demand for efficient diagnostic solutions. It is expected to drive the utilization of Q-PCR and D-PCR devices, displaying the significance of molecular diagnostic technologies in meeting the testing needs during public health crises
- In May 2023, Standard BioTools launched the X9 High-Throughput Genomics System, enabling users to conduct both RT-PCR and NGS-based applications on a single benchtop platform. This innovation streamlines laboratory workflows, offering efficiency and versatility. The system's capability to perform multiple molecular biology techniques addresses the demand for integrated solutions in the Q-PCR and D-PCR devices market, potentially reshaping the landscape of genomic analysis
- In March 2023, BGI Genomics and Zentya collaborated to introduce a PCR fecal test for colorectal cancer in Slovakia. This strategic partnership combines BGI's expertise in genomics with Zentya's local market knowledge, aiming to enhance early detection of colorectal cancer. The introduction of this PCR-based screening test reflects the growing utilization of molecular diagnostic technologies, potentially driving demand in the Q-PCR and D-PCR devices market
Global Q-PCR and D-PCR Devices Market Scope
The global Q-PCR and D-PCR devices market is segmented on the basis of technology, products and services, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Quantitative PCR
- Digital PCR
Products and Services
- Reagents
- Consumables
- Instruments
- Software
Application
- Clinical Applications
- Research
- Forensic
- Others
End User
- Hospitals
- Diagnostic Centres
- Research Laboratories
- Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Forensic Laboratories
Global Q-PCR and D-PCR Devices Market Regional Analysis/Insights
The global Q-PCR and D-PCR devices market is analysed and market size insights and trends are provided by technology, products and services, application and end user as referenced above.
The countries covered in the global Q-PCR and D-PCR devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the Q-PCR and D-PCR devices market persists due to sustained demand for rapid diagnostic tests and widespread adoption of genomic analysis tools. This trend is expected to drive substantial growth in the region throughout the forecast period, reflecting the region's prominence in molecular diagnostics.
Asia-Pacific is expected to experience the highest compound annual growth rate (CAGR) in the forecast period. The increasing prevalence of chronic diseases and ongoing enhancements in healthcare infrastructure, particularly in developing nations, are key factors propelling market expansion in the region, indicating significant growth potential.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The global Q-PCR and D-PCR devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global Q-PCR and D-PCR devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global Q-PCR and D-PCR devices market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Q-PCR and D-PCR Devices Market Share Analysis
The global Q-PCR and D-PCR devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global Q-PCR and D-PCR devices market.
Some of the major players operating in the global Q-PCR and D-PCR devices market are:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc.(U.S.)
- Bio-Rad Laboratories, Inc.(U.S.)
- QIAGEN (Germany)
- Takara Bio Inc. (Japan)
- Agilent Technologies, Inc.(U.S.)
- bioMérieux SA (France)
- Danaher(U.S.)
- Abbott (U.S.)
- Merck KGaA (Germany)
- BD(U.S.)
- Promega Corporation(U.S.)
- Eppendorf AG (Germany)
- Analytik Jena GmbH (Germany)
- Meridian Bioscience, Inc.(U.S.)
- Enzo Life Sciences, Inc.(U.S.)
- Cole-Parmer Instrument Company, LLC.(U.S.)
- BIONEER CORPORATION (South Korea)
- ELITechGroup (France)
- Quantabio(U.S.)
SKU-